Healthcare >> CEO Interviews >> January 10, 2001
ALFRED E. MANN has served as Chairman of the Board and Chief Executive
Officer of MiniMed, Inc., and its predecessor's partnership since its
founding in 1985. Since 1994, Mr. Mann has also served as Chairman and
CEO of Advanced Bionics Corporation, which is the successor to the
electrostimulation business segment of MiniMed's predecessor. He is also
the Chairman of Medical Research Group, which is developing a prosthetic
artificial pancreas. Mr. Mann is also Chairman of Second Sight LLC,
which is developing a visual prosthesis for the blind; CTL Immunotherapy
Inc., which is developing therapeutic vaccines for cancer and other
chronic diseases; Allecure, which is developing therapies to control
allergies and asthma; and Pharmaceutical Discovery Corporation, which
has developed an encapsulation capability for pulmonary and oral
delivery of proteins and peptides. Mr. Mann also is Chairman of the
Board of Directors at the Alfred E. Mann Foundation and the Alfred E.
Mann Institute for Biomedical Research at the University of Southern
California, both not-for-profit research and development corporations
devoted to the development of medical devices and associated technology.
From 1985 to September 1992, Mr. Mann was also President and CEO of
Siemens-Pacesetter, Inc., a manufacturer of cardiac pacemakers. Mr. Mann
founded, and from 1972 until 1985, was Chairman of the Board and CEO of
Pacesetter Systems, Inc., a California corporation and predecessor of
Siemens-Pacesetter, Inc. Prior to 1972, he was President of Spectrolab,
an electro-optical and aerospace systems company, and Heliotek, a
semiconductor and electro-optical components manufacturer. Mr. Mann
founded these companies in 1956 and 1960, respectively; they were sold
to Textron Inc. in 1960. Mr. Mann is also Chairman of the Southern
California Biomedical Council, a not-for-profit organization devoted to
expanding opportunities for the biomedical industry and institutions,
especially in the greater Los Angeles region. Mr. Mann holds an MS
degree in Physics from the University of California, Los Angeles. Profile
MiniMed?
Mr. Mann: MiniMed is a company primarily involved in chronic disease
management, with a principal focus today on
